Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Raysearch Laboratories Ab recalls RayStation with the following product descriptions: 1. RayStation 2023B

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
DICOM SOP Instance UID and Series Instance UID from RayGateway, i.e. the interface to Accuray's iDMS, are not guaranteed to be unique.
Products
  • RayStation with the following product descriptions: 1. RayStation 2023B
Where it was sold

Worldwide - US Nationwide distribution in the states of AL, CA, FL, GA, IL, IA, KY, LA, MD, MN, MS, NY, NC, OH, OK, SC, WA, WI and the countries of Canada, China, Colombia, France, Germany, Hong Kong S.A.R., China, Italy, Japan, Netherlands, Poland, Spain, Sweden, Switzerland, ENG, Thailand, Turkey, UK, Ukraine.

States: Alabama, California, Florida, Georgia, Iowa, Illinois, Kentucky, Louisiana, Maryland, Minnesota, Mississippi, North Carolina, New York, Ohio, Oklahoma, South Carolina, Washington, Wisconsin

Units affected
49
About this recall
RayStation with the following product descriptions: 1. RayStation 2023B, Software Version: 14.0.0.3338. 2. RayStation 2024A, Software Version: 15.0.0.430. 3. RayStation 2024A SP3, Software Version: 15.1.3.10. Product Description: Radiation Therapy Treatment Planning System.